Magnet therapy patch for treating cardiovascular disease and manufacturing method

Abstract

The invention relates to the technical field of medical treatment, in particular to a magnet therapy patch capable of being effectively used for treating a cardiovascular disease and a manufacturing method. The patch is composed of a patch body (medical proof fabric adhesive layer and protection layer), a magnet therapy layer made of magnetic materials and viscous agents and the like, the patch can be made to any shape according to use needs, and the patch has the advantages of improving blood circulation and human heart functions, strengthening the myocardial contraction force, improving angiotasis, eliminating inflammation of the blood vessel walls, strengthening the vitality of cells, improving the metabolism, reducing transmission of pain signals, preventing cholesterol precipitation, preventing myocardial infarction and thrombosis forming and the like, and is used for treating the cardiovascular disease, various inflammations, inflammatory edema, vascular scars and vascular sclerosis. Before the patch is used, different specifications and models are selected according to needs, when the patch is used, the protection layer is removed, the magnet therapy layer and the medical proof fabric adhesive layer in the patch body are directly and tightly attached to the precordium and the heart shu-acupoint, and each patch can be used for 1-2 days.

Description

technical field [0001] The invention belongs to the field of medical technology, and in particular relates to a magnetic therapy paste capable of effectively treating cardiovascular diseases and a production method thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are the number one killer of disease deaths. In the past 10 years, the morbidity, mortality and risk factors of cardiovascular and cerebrovascular diseases have shown a linear upward trend. The number of deaths due to cardiovascular and cerebrovascular diseases in China is about 2.6 million every year, accounting for about The total death rate is 40.72%, which has caused a huge health threat to human beings and seriously affected the quality of life of patients; and the current progress in the prevention and treatment of cardiovascular diseases cannot fundamentally solve the problem that the incidence and mortality of cardiovascular diseases are increasing year by year. problem, and...

AI Technical Summary

Problems solved by technology

[0002] Cardiovascular and cerebrovascular diseases are the number one killer of disease deaths. In the past 10 years, the incidence, mortality and risk factors of cardiovascular and cerebrovascular diseases have shown a linear upward trend. The number of deaths due to cardiovascular and cerebrovascular diseases in China is about 2.6 million every year, accounting for about The total death rate is 40.72%, which has caused a huge health threat to human beings and seriously affected the quality of life of patients; and the current progress in the prevention and treatment of cardiovascular diseases cannot fundamentally solve the problem that the incidence and mortality of cardiovascular diseases are increasing year by year. problem, and the existing treatment technology has the following deficiencies: 1. surgery: stent or tower bridge surgery is only used to save life and relieve symptoms, but does not solve the fundamental pathogenesis of vascular disease, and is subject to the surgical index of vascular blockage degree In the process of waiting to reach the surgical index, individual patients died suddenly, and patients who exceeded the surgical index were helplessly waiting for death; 2. Drug treatment: Generally, western medicine treats cardiovascular diseases mainly by dilating blood vessels. However, after the drug is absorbed and filtered into the whole body through the viscera, there is not only the peak and valley phenomenon of the drug rapidly dilating blood vessels, but there is a certain risk of bleeding, and it cannot play a uniform and continuous drug effect, and the drug-induced damage is relatively large. Very unsatisfactory; 3. The method of directly implanting permanent magnets into the human body is more complicated, and the implantation process is dangerous or harmful to the human body; 4. The method of directly binding and fixing the permanent magnets on the skin to treat cardiovascular diseases lacks comfort and is easy to fall off, and is not easy to be damaged. Accepted; 5. Lack of effective combination of magnets and viscous agents; so the treatment of cardiovascular diseases is tricky